Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA approves Genentech’s Ocrevus for multiple sclerosis treatment In a landmark decision, the US Food and Drug Administration (FDA) has granted approval to Genentech, a subsidiary… bypharmanewsdailyApril 2, 2017
